Literature DB >> 3570381

Molecular diversity of HLA-DQ. DQ alpha and beta chain isoelectric point differences and their relation to serologically defined HLA-DQ allospecificities.

R E Bontrop, E J Baas, N Otting, G M Schreuder, M J Giphart.   

Abstract

HLA-DQ molecules were isolated from a panel of HLA-DR-DQ homozygous cell lines, partially of consanguineous origin, derived by the use of monoclonal antibody SPV-L3, and subsequently analyzed by gel electrophoretic techniques. It is demonstrated that both the DQ alpha and beta chain exhibit an extensive isoelectric point polymorphism. Within a panel of 29 B-cell lines tested, at least 5 distinct alpha and 6 distinct DQ beta chain gene products were observed. Of the 30 theoretically possible DQ alpha-beta dimers, only 10 could be identified within the panel: 5 different dimers are associated with the DQw1 allospecificity; HLA-DQw2 and -DQw3 are associated with 2 types of dimers, whereas another DQ alpha-beta combination was expressed by a cell line with a so-called DQ-blank specificity. The relation between the specificities 2B3 and TA10 appeared to be complicated as far as DQ beta chain isoelectric point differences are concerned: monoclonal antibody IIB3 seems to be reactive with four distinct DQ beta chain alleles whereas monoclonal antibody TA10 only reacted with one type of DQ beta chain. These results suggest that the polymorphic DQ alpha and beta chains may both contribute to the definition of the HLA-DQ allospecificity. A particular DQ beta chain was present in two types of HLA-DQw1 molecules, as well as in one type of HLA-DQw2 and -DQw3 (2B3 positive) molecule, and formed dimers with electrophoretic distinct DQ alpha chains. On the other hand, HLA-DQw2 molecules isolated from HLA-DR3-positive cells and one type of HLA-DQw3 (TA10 positive) molecule were found to be constructed of identical alpha chains but appeared to differ in the composition of their DQ beta chain gene products. The implications of these findings will be discussed.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3570381     DOI: 10.1007/bf00404423

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  35 in total

1.  Identification of a polymorphic variant associated with HLA-DQw3 and characterized by specific restriction sites within the DQ beta-chain gene.

Authors:  S J Kim; S L Holbeck; B Nisperos; J A Hansen; H Maeda; G T Nepom
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

2.  DQ alpha and beta RFLP reveals the composition of the DQ molecule recognized by T-cell clones.

Authors:  S Rosenshine; I Cascino; A Zeevi; R J Duquesnoy; M Trucco
Journal:  Immunogenetics       Date:  1986       Impact factor: 2.846

3.  Six HLA-D region alpha-chain genes on human chromosome 6: polymorphisms and associations of DC alpha-related sequences with DR types.

Authors:  R S Spielman; J Lee; W F Bodmer; J G Bodmer; J Trowsdale
Journal:  Proc Natl Acad Sci U S A       Date:  1984-06       Impact factor: 11.205

4.  The heavy chain of human B-cell alloantigen HLA-DS has a variable N-terminal region and a constant immunoglobulin-like region.

Authors:  H C Chang; T Moriuchi; J Silver
Journal:  Nature       Date:  1983 Oct 27-Nov 2       Impact factor: 49.962

5.  Gene interaction at HLA-DQ enhances autoantibody production in primary Sjögren's syndrome.

Authors:  J B Harley; M Reichlin; F C Arnett; E L Alexander; W B Bias; T T Provost
Journal:  Science       Date:  1986-05-30       Impact factor: 47.728

6.  HLA-DQ beta-chain polymorphism linked to myasthenia gravis.

Authors:  J Bell; L Rassenti; S Smoot; K Smith; C Newby; R Hohlfeld; K Toyka; H McDevitt; L Steinman
Journal:  Lancet       Date:  1986-05-10       Impact factor: 79.321

7.  Cloning and sequence analysis of the human major histocompatibility complex gene DC-3 beta.

Authors:  J M Boss; J L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  1984-08       Impact factor: 11.205

8.  Hybrid HLA-DC antigens provide molecular evidence for gene trans-complementation.

Authors:  D J Charron; V Lotteau; P Turmel
Journal:  Nature       Date:  1984 Nov 8-14       Impact factor: 49.962

9.  Both alpha and beta chains of HLA-DC class II histocompatibility antigens display extensive polymorphism in their amino-terminal domains.

Authors:  L Schenning; D Larhammar; P Bill; K Wiman; A K Jonsson; L Rask; P A Peterson
Journal:  EMBO J       Date:  1984-02       Impact factor: 11.598

10.  An HLA-D region restriction fragment length polymorphism associated with celiac disease.

Authors:  M D Howell; R K Austin; D Kelleher; G T Nepom; M F Kagnoff
Journal:  J Exp Med       Date:  1986-07-01       Impact factor: 14.307

View more
  3 in total

1.  RFLP analysis of the HLA-, ChLA-, and RhLA-DQ alpha chain gene regions: conservation of restriction sites during evolution.

Authors:  R E Bontrop; N Otting; L A Broos; M C Noort; M Kenter; M Jonker
Journal:  Immunogenetics       Date:  1989       Impact factor: 2.846

2.  Major histocompatibility complex class II-restricted antigen presentation across a species barrier: conservation of restriction determinants in evolution.

Authors:  R E Bontrop; D G Elferink; N Otting; M Jonker; R R de Vries
Journal:  J Exp Med       Date:  1990-07-01       Impact factor: 14.307

Review 3.  Molecular basis of human leukocyte antigen class II disease associations.

Authors:  D Charron
Journal:  Adv Immunol       Date:  1990       Impact factor: 3.543

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.